ROCHE TO COPROMOTE SMITHKLINE's COREG FOLLOWING CORANGE ACQUISITION; BOEHRINGER MANNHEIM CARDIOVASCULAR LINE OFFERS INFRASTRUCTURE FOR ROCHE POSICOR LAUNCH
• By The Pink Sheet
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".